title: Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab.
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Cornillier
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Thibault
authors.initials: T
authors.lastname: Kervarrec
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Flore
authors.initials: F
authors.lastname: Tabareau-Delalande
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Saloua
authors.initials: S
authors.lastname: Mammou
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Annie-Pierre
authors.initials: AP
authors.lastname: Jonville Bera
authors.affiliation: Services de Dermatologie, Anatomie Pathologique, Rhumatologie, Pharmacologie clinique CHRU de Tours, INSERM U 930, Université François Rabelais, Tours, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Machet
mesh_terms: D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D000328:Adult; D003872:Dermatitis / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006099:Granuloma / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D000069549:Ustekinumab / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000069549:Ustekinumab; D000077339:Leflunomide